Can you clear out "zombie cells" to slow down ageing?
In animal research, clearing zombie cells is impressively effective, but in humans the evidence is still very preliminary. Wait for larger trials before acting on this, and avoid self-medicating with senolytics.
Senescent cells, also known as zombie cells, accumulate as you get older. They stop dividing themselves but do not die off. Instead, they secrete a cocktail of inflammatory substances that damage surrounding tissue and contribute to diseases such as cardiovascular disease, dementia and metabolic disorders. Multiple reviews confirm this pattern, and the link with ageing is biologically well established.
Not all zombie cells are purely harmful. When they are active briefly and temporarily, they protect against cancer and suppress scar tissue formation, for example. It is the years-long accumulation that becomes the problem, not the cell itself. This makes targeted clearance more complicated than it sounds.
In animal research, so-called senolytics work convincingly: agents such as dasatinib, quercetin and fisetin cause senescent cells to die off in a targeted way. Aged mice recovered in fitness, coat density and kidney function, and more than forty conditions were slowed or alleviated. The animal studies are consistent and broadly replicated. In humans, the first small pilot studies are cautiously positive: fewer senescent cells, less inflammation, less frailty. But these are small studies without the scale to draw firm conclusions. Larger trials for conditions such as pulmonary fibrosis, diabetes and Alzheimer's disease are still under way.
A second approach involves senolytics, such as mTOR or JAK inhibitors. These do not kill senescent cells but dampen their harmful inflammatory secretion. Here too, the evidence in humans remains limited.
Self-medicating with senolytics is not responsible at this point in time. Navitoclax, for example, can dangerously lower platelet counts. Moreover, reliable methods for measuring whether a treatment actually works are lacking: senescent cells vary so much by tissue and life stage that no well-usable biomarker yet exists for them. Caloric restriction and exercise modulate the same biological pathways in a safer way, although that evidence is less direct. Anyone interested in senolytics is best advised to do so through a clinical trial.
All sources are reviews (no original RCTs or meta-analyses with pooled data). Animal studies are robust; human evidence is limited to small pilot studies.
What are "zombie cells" and how do you get rid of them?
Zombie cells clearly play a role in ageing, but no proven treatment yet exists for humans. Keep an eye on the field, but for now do not stock up on supplements or products claiming to be senolytics.
What do zombie cells do to your ageing?
Zombie cells accumulate as you age and accelerate ageing through inflammatory signals; how to tackle them is promising but still very much under investigation.
Does fisetin from strawberries really work as a zombie-cell cleaner?
Fisetin demonstrably clears zombie cells in lab and mouse research, but whether this also works in humans and is safe has not yet been established. Do not take it as a supplement outside clinical studies for the time being.
Can you repair DNA damage, or can you only prevent it?
Your body actively repairs DNA damage through multiple well-studied mechanisms, but that repair is not always perfect and becomes less effective when the cell is under excessive strain or grows older.
Does clearing senescent cells with senolytics help against ageing?
Senolytics show impressive results in mouse studies, but in humans the evidence is too thin for use outside clinical trials. Self-medication with Dasatinib is inadvisable due to its side effects and cancer-biology risks.
Why do your telomeres get shorter as you age?
Telomere shortening is part of life: every cell division costs a piece. But smoking, chronic stress, and sleep deprivation demonstrably accelerate that process. That acceleration is therefore something you can partly influence yourself.